Every article, presentation, spotlight, and news item we've tagged to Longevity Services & Practice.
The longevity field has more tools than ever. What's lagging behind is the number of practitioners trained to use them in an integrated, personalized way. Here's how longevity education is closing the gap.
Most biohackers fail because they optimize before eliminating what's sabotaging their biology. Discover why removing interference beats adding interventions—and how to finally make your health stack work.
The tools of longevity optimization don't emerge in a vacuum. Behind every evidence-based intervention is a research pipeline, a regulatory pathway, and a funding decision that determines whether it ever reaches you.
Unlock the power of precision health monitoring with Dr. Jin-Xiong She, founder of Jinfiniti and pioneer in cellular energy optimization. This essential session reveals how strategic health metric testing transforms guesswork into actionable insights for longevity. Learn to decode your body's molecular signals, from NAD+ levels to biomarkers that matter most. Dr. She shares proven frameworks for selecting the right tests, interpreting results, and creating personalized optimization protocols that deliver measurable results for healthspan extension.
Longevity educator and podcaster Nathalie Niddam explores bioregulators—tiny peptide chains that penetrate directly into cells to activate DNA repair and restore gene expression. Drawing from the groundbreaking work of Professor Khavinson's peptide theory of aging, this session demystifies how these two-to-four amino acid complexes differ from conventional peptides, why they don't need receptors to work, and how they address aging at the cellular motherboard. Niddam shares her favorite six "desert island" bioregulators and explains their role in a comprehensive longevity strategy, while navigating the evolving regulatory landscape and distinguishing between synthetic and animal-derived formulations.
Former insurance mortality expert Gary Brecka reveals groundbreaking insights from 22 years of predicting human lifespans to the month. Drawing from exclusive life insurance data on 370 million lives, Brecka exposes how oxygen depletion drives aging and disease through hypoxic curves. He shares the science behind modifiable risk factors that could add seven years to your healthspan, explores the hidden connections between hormone balance and oxygen transport, and explains why most health conditions aren't consequences of aging but correctable deficiencies. A data-driven approach to unlocking longevity secrets.
Join Therasage CEO Robby Besner as he unveils the "toxic toolkit" threatening our health and the simple, affordable interventions we can deploy today. Drawing from 40 years of naturopathic practice and his breakthrough work with infrared technology, Besner reveals how ancient healing wisdom combined with modern biohacking tools can help us thrive despite living in an increasingly toxic world. Learn practical strategies to combat environmental toxins, reduce inflammation, and harness nature's healing frequencies for optimal longevity.
Elite athletes understand that performance isn't built through shortcuts but through consistent, strategic choices. Former UFC champion Miesha Tate applies these proven principles to help everyday people optimize their health and longevity.
Join bioEDGE Coach founder Sandy Martin as she moderates an insightful panel exploring the true meaning of biohacking beyond the hype. Featuring Jean Fallacara from Lifespanning and longevity enthusiast Dave Pascoe, this discussion reveals diverse approaches to optimization—from brain-first strategies to supplement cycling. Discover practical insights on starting your biohacking journey, the importance of eliminating toxins before adding supplements, and why happiness might be the ultimate biohack. Perfect for beginners and experienced biohackers seeking evidence-based perspectives on health optimization.
Dr. Melissa Petersen, founder of the Human Longevity Institute, demystifies epigenetics and reveals how your DNA is not your destiny—it's your potential. Through personal storytelling and accessible science, she explains methylation, biological age testing, and the concept of the longevity escape velocity. Discover how the quality of inputs—from thoughts to foods to relationships—directly communicates with your DNA, either repressing or expressing your innate potential. With her biological age at 42 despite being chronologically 52, Dr. Petersen demonstrates that aging is optional, not inevitable.
Sandy Martin, Founder of bioEDGE Coach, challenges the 'more is better' mentality plaguing modern biohacking. In this eye-opening session, discover why your expensive supplement stack and endless optimization protocols might be sabotaging your health goals. Sandy reveals the counterintuitive power of saying 'NO' to create space for what truly moves the needle in longevity and performance. Learn to cut through biohacking noise, identify what's actually working, and build a sustainable foundation for long-term health optimization.
Discover how epigenetic testing reveals your true biological age versus chronological age with Ryan Smith, founder of TruDiagnostic. Learn how DNA methylation patterns can predict health outcomes with 92% accuracy and track the effectiveness of longevity interventions in real-time. Smith reveals how aging is the #1 risk factor for chronic disease—10x more significant than smoking or obesity—and demonstrates how epigenetic clocks can measure biological aging from a single drop of blood, providing over 100 biomarkers to optimize your health span.
Carlos Bertonatti, Clinic Director of Miami's Medical Health Institute, delivers a high-energy session exposing the dangerous gap between our ancestral biology and modern living. Opening with an unconventional biohack demonstration, Bertonatti reveals the "three silent killers" conventional medicine ignores—particularly endocrine-disrupting chemicals (EDCs) that are quietly destroying our hormonal systems. Drawing from his extensive self-experimentation as an extreme athlete and his clinic's work in hormone optimization and functional medicine, he confronts shocking statistics: 93% of Americans suffer metabolic dysfunction, while EDCs silently sabotage our cellular machinery. This isn't theoretical wellness talk—it's a practical wake-up call grounded in the fundamentals that 95% of people get wrong.
Naturopathic doctor Judy Seeger dismantles the myths and marketing hype surrounding women's longevity, delivering evidence-based strategies grounded in 30 years of clinical practice. This session cuts through the $77 billion wellness industry targeting women to reveal what actually works for healthy aging. Seeger addresses the critical gap in research—most studies are conducted on men—and provides women-specific guidance on protein needs, digestive health, movement patterns that boost brain health, stress management through grounding, and quality sleep. With practical tools like diagnostic belly checks and exercise snacks, she offers a strategic framework for reversing age-related decline without spending unnecessarily on supplements and quick fixes.
What if aging isn't the inevitable decline we've been told it is? Dr. Ian White, regenerative medicine pioneer and founder of Neobiosis, challenges conventional thinking about biological aging by exploring nature's most radical examples—from immortal jellyfish that reverse their age to lobsters that never age at all. Drawing on two decades of stem cell research at Harvard, Cornell, and beyond, he presents compelling evidence that aging can be accelerated, slowed, paused, and even reversed. This provocative session examines the mechanisms behind age reversal, from Yamanaka factors to perinatal tissues, and explores whether regenerative medicine holds the key to treating aging itself as a disease.
Scientists discovered how NAD+, exosomes, and DNA repair enzymes can reverse skin aging at the cellular level. Young Goose harnesses these longevity pathways to regenerate skin from within.
Ben Azadi, founder of Keto Kamp and author of the New York Times bestseller Metabolic Freedom, reveals why most biohackers are unknowingly harming their health despite optimizing protocols. Through the concept of hormesis and practical demonstrations, Azadi explains how cold plunges, fasting, and red light therapy can become toxic stressors when your "stress bucket" is full. Drawing from his personal battle with Raynaud's syndrome and mercury poisoning, he shares the six science-backed strategies he used to raise his hormetic ceiling—including high-dose melatonin, mouth taping, and HRV tracking—enabling him to finally thrive with metabolic flexibility.
Bioregulator peptides are short-chain amino acid sequences designed to support tissue-specific gene expression that naturally declines with age. Longevity educator Nathalie Niddam explains how personalized peptide strategies, built on solid foundations, may help restore the body's own regulatory signals.
Singapore's Chi Longevity clinic exemplifies a clinical shift toward prevention and precision health in aging populations, grounded in structured diagnostics and longitudinal biomarker tracking rather than episodic care. This model demonstrates how preventive medicine translates from policy aspiration into operational practice through physician-led assessment pathways and individualized risk stratification.
A women-focused wellness retreat in Bali is repositioning around functional longevity, moving beyond spa-based pampering toward practical health optimization. The model addresses a market gap by making longevity science accessible to women through experiential protocols rather than clinical metrics.
Longevity medicine has entered clinical practice ahead of its evidence base, creating a gap between consumer demand and scientific rigor. Establishing clinical registries, standardized protocols, and rigorous trial infrastructure is essential for the field to transition from a commercial marketplace to a credible medical discipline.
Innovative Vitality launched Longevity Labs & Provider Review, a lower-commitment program that combines comprehensive biomarker analysis (50+ markers), body composition assessment, and a one-hour clinician consultation to identify health gaps between normal lab results and how patients actually feel. The program delivers a personalized health roadmap without requiring ongoing enrollment, addressing the clinical limitation that normal test results often mask suboptimal function.
Morrow, a Singapore-based longevity clinic, is redesigning accessible healthcare by linking everyday behaviors to measurable health outcomes rather than offering expensive biomarker panels to elites. The model uses lifestyle medicine pillars (diet, activity, stress, sleep, substance avoidance, social connection) paired with AI-assisted monitoring to democratize longevity care for median-income populations.
Structured longevity medical education is transitioning from fragmented knowledge to standardized clinical pathways, with the pairing of academic rigor (NUS Academy for Healthy Longevity) and practical implementation (Longevity Academy) signaling institutional maturation of the field. This development addresses the persistent gap between scientific discovery and clinical practice, establishing longevity medicine as a legitimate career pathway rather than a peripheral specialty.
Structured education in longevity medicine measurably shifts physician confidence and clinical behavior across 42 countries. This represents the first empirical evidence that teaching evidence-based aging biology translates into actionable changes in routine medical practice—closing a significant gap between longevity science and clinical delivery.
Catalyst Precision Health launches an integrated model combining in-home testing, physician house calls, and continuous personalized care for men's longevity, addressing fragmentation in the current market where health data remains scattered across disconnected providers and platforms.
Private longevity clinics are transitioning from theoretical frameworks to clinical practice, but without standardized pathways, creating variability in how preventive interventions are delivered. The challenge now centers on establishing clinical rigor—distinguishing measurable biomarkers from clinically meaningful outcomes—while building scalable, evidence-led models that can eventually extend beyond premium markets.
Vail Health's clinical leadership argues that foundational prevention practices—exercise, sleep, strength training, social connection, and purpose—remain the most impactful drivers of longevity, and that advanced diagnostics add value only when they prompt behavioral change. This reframes the longevity conversation away from technology and supplements toward the habits most people neglect.
Innovative Vitality launched a short-term membership program offering comprehensive biomarker analysis, body composition assessment, and personalized health planning for $549. The service targets individuals with persistent health concerns despite normal conventional lab results, providing a lower-commitment entry point to data-driven longevity optimization.
Serotonin Centers is establishing medical longevity suites within existing fitness facilities across the US, integrating diagnostic assessment and clinical interventions (hormone optimization, GLP-1 therapy, peptide protocols, recovery technologies) directly into gyms. This model addresses the recognition that exercise alone is insufficient for sustained health optimization and positions gyms as access points for comprehensive, medically supervised longevity care.
Serotonin Centers launched a medical longevity model enabling fitness facilities to integrate medically supervised services including hormone optimization, peptide therapies, and metabolic support within existing spaces. The turnkey approach addresses growing consumer demand for integrated health solutions that extend beyond traditional fitness training.
The 2026 Longevity Show has announced its first partners, representing a shift in how longevity research is being translated into clinical practice and consumer applications. The roster spans diagnostics, nutrition, regenerative medicine, AI, and clinical services—signaling a field consolidating around integrated systems that deliver measurable health outcomes rather than isolated interventions.
The inaugural Longevity Innovation Forum, held March 11–12, 2026 in San Diego, convenes leading researchers, clinicians, biotech founders, and investors to advance the science and clinical translation of healthy aging. The event addresses biomarkers of longevity, epigenetic clocks, cellular rejuvenation, and strategies to modulate biological drivers of aging across multiple research domains.
France has implemented a nationwide integrated care program (ICOPE) for older adults that prioritizes functional capacity and well-being over disease management alone. This person-centered approach offers a scalable model for other nations seeking to optimize health outcomes in aging populations.
The Asia-Pacific Longevity Medicine Society and Kitalys Institute will host a 2026 summit in Hong Kong to translate longevity research into clinical practice at scale. The event brings together 2,000+ leaders across medicine, geroscience, digital health, and policy to establish standards and delivery models for personalized longevity interventions.
The Buck Institute launched Healthspan Horizons, a research infrastructure platform that integrates longitudinal multi-modal health data from wearables, activity, nutrition, and labs to identify patterns driving healthy aging and detect early disease signals. This addresses the critical gap between lifespan extension and healthspan maintenance—the years lived in functional health rather than chronic disease management.
The Xplore Program is a fully remote summer fellowship designed to translate longevity interest into practical biotech experience through structured education and direct project placement with partner organizations. The program addresses a critical gap: making the pathway into longevity science explicit and accessible to talented individuals outside major biotech hubs.
Occupational health is shifting from compliance and risk mitigation toward prevention and long-term healthspan management, with employers increasingly positioned as agents of intervention during midlife—a critical window for altering disease trajectories. This convergence creates both opportunity and tension: while employers can scale prevention through their workforce, questions of privacy, data ownership, and equity remain unresolved.
The Longevity Show 2026 has partnered with Peloton to embed structured movement into longevity programming through experiential sessions and community-based activities. This signals a strategic pivot from laboratory biomarkers toward operationalizing the behavioral and adherence mechanisms that translate longevity science into sustained practice.
Longevity.Technology has transitioned from a media platform into an AI-native data infrastructure company, launching DLT (Decoding Longevity Trends), a three-stage system that aggregates, validates, and surfaces actionable intelligence on longevity and age-related disease biotechs. This infrastructure shift enables precision decision-making for investors, founders, and pharmaceutical development teams across a rapidly fragmenting landscape of aging research.
Supernatural, a Toronto retail concept, packages longevity and health optimization as an accessible consumer experience, partnering with functional medicine to create a diagnostic-led pathway that lowers entry barriers while maintaining measurable outcomes. This model addresses the gap between longevity science and sustained behavioral adoption by integrating recovery technologies, personalized testing, and ongoing clinical support into an intuitive lifestyle environment.
Wisp, a women-focused telehealth platform, has launched a longevity category offering NAD+, glutathione, and low-dose naltrexone through clinician-guided care rather than biohacking positioning. The move addresses a significant gap: 75% of women prioritize long-term health, yet only 11% feel current digital tools provide meaningful control over aging outcomes.
